Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1)

 EDITORIAL SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):1-3

PET beyond 18F-FDG: second generation PET tracers in clinical oncology

Brouwers A. H., Glaudemans A. W. J. M., De Vries E. F. J.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):4-17

Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone

Talbot J.-N., Gligorov J., Nataf V., Montravers F., Huchet V., Michaud L., Ohnona J., Balogova S., Cussenot O., Daraï E., Lotz J.-P., Kerrou K.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):18-38

89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?

Van Dongen G. A., Huisman M. C., Boellaard R., Harry Hendrikse N., Windhorst A. D., Visser G. W. , Molthoff C. F., Vugts D. J.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):39-57

Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles

Peeters S. G., Zegers C. M., Yaromina A., Van Elmpt W., Dubois L., Lambin P.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):58-69

Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP)

Ambrosini V., Morigi J. J., Nanni C., Castellucci P., Fanti S.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):70-82

Applications of PET imaging of neurological tumors with radiolabeled amino acids

Galldiks N., Langen K.-J.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):83-94

Applications of PET imaging with radiolabelled choline (11C/18F-choline)

Kirienko M., Sollini M., Lopci E., Versari A., Chiti A.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):95-104

Applications of PET imaging with the proliferation marker [18F]-FLT

Peck M., Pollack H. A., Friesen A., Muzi M., Shoner S. C., Shankland E. G., Fink J. R., Armstrong J. O., Link J. M., Krohn K. A.


 REVIEWS SECOND GENERATION PET TRACERS IN ONCOLOGY 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):105-15

Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals

Lauri C., Di Traglia S., Galli F., Pizzichini P., Signore A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):116-20

Comparison of 68Ga-DOTATOC biodistribution in patients with and without spleenectomy

Kratochwil C., Mavriopoulou E., Rath D., Afshar-Oromieh A., Apostolopoulos D., Haufe S., Mier W., Haberkorn U., Giesel F. L.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):121-8

Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis

Fu H., Ma C., Tang L., Wu F., Liu B., Wang H.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 March;59(1):129-35

Precise fusion of MRI and dual energy 111In WBC/99mTc HDP SPECT/CT in the diabetic foot using companion CT: an example of SPECT/MRI imaging

Knešaurek K., Kolker D., Vatti S., Heiba S.


top of page